Citigroup Maintains Neutral on NOV, Lowers Price Target to $21

Benzinga Newsdesk www.benzinga.com Negative 88.2%

Neg 88.2% Neu 0% Pos 0%

Citigroup analyst Scott Gruber maintains NOV (NYSE:NOV) with a Neutral and lowers the price target from $22 to $21.

Comments

No comments yet. Be the first!